Alx Oncology Holdings (ALXO) Price to Earnings (2020 - 2026)
Powered by 
Analysis
Alx Oncology Holdings (ALXO) Price to Earnings (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.74 Bn | 130.89 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.52 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.04 Bn | 52.91 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.88 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.46 Bn | 32.15 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Alx Oncology Holdings | 273.99 Mn | 273.99 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17.02 |
| Mar 31, 2026 | -10.74 |
| Dec 31, 2025 | -2.69 |
| Sep 30, 2025 | -4.43 |
| Jun 30, 2025 | -0.85 |
| Mar 31, 2025 | -1.02 |
| Dec 31, 2024 | -3.04 |
| Sep 30, 2024 | -3.13 |
| Jun 30, 2024 | -7.52 |
| Mar 31, 2024 | -14.59 |
| Dec 31, 2023 | -16.37 |
| Sep 30, 2023 | -3.87 |
| Jun 30, 2023 | -8.24 |
| Mar 31, 2023 | -5.80 |
| Dec 31, 2022 | -15.03 |
| Sep 30, 2022 | -11.04 |
| Jun 30, 2022 | -9.57 |
| Mar 31, 2022 | -27.10 |
| Dec 31, 2021 | -30.67 |
| Sep 30, 2021 | -121.73 |